What are your top takeaways in GU Cancers from ASTRO 2024?
Community PollStarted
Are you routinely implementing focal microboost for definitive treatment of prostate cancer for those who are good candidates (lesion visible MRI, IPSS<20, no prior pelvic radiation, no regional or distant metastases, etc)?
53 physicians have voted
Join Mednetto vote and see how they answered.
6 Answers
Mednet MemberInvited Expert
Radiation Oncology · UC San Diego
Answered on
- The Presidential Symposium was outstanding. Dr. Brandon Mahal’s presentation hit on a top priority for the field, in my view: how do we improve/accelerate the implementation of advances like focal microboost for prostate cancer? RCT evidence of benefit to dose escalation is rare in rad onc. The FLA...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · UPMC Hillman Cancer Center
Answered on
- PARTIQoL: This phase III trial randomized 450 men with low- or intermediate-risk prostate cancer to receive definitive external beam radiation therapy with either photons (control arm) or protons (experimental arm). The radiation dose/fractionation was either conventional fractionation or moderate...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · Virginia Commonwealth University Medical Center
Answered on
- @Dr. First Last, MD, PhD presented the results of the PARTIQoL trial, a Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Localized Prostate Cancer. Patients with intermediate- or low-risk prostate cancer were randomized to PBT or IMRT, without hormonal therapy, stratified for inst...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · St. Francis Radiation Oncology
Answered on
The PARTIQoL study being negative was huge - and validates what we saw in our claims-based analyses.
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · Duke University Medical Center
Answered on
The PARTIQoL trial can help reassure patients that they need not travel long distances to receive proton therapy for their localized prostate cancer.
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · University of Michigan
Answered on
The plenary on prostate (proton vs photon) - both arms did very well, no clear benefit of protons
Join for free or sign in to see the full answer